Showing results (541-550 of 559) with videos related to
Sort By:
Pageof 56
Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2022
Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe ExtensionDavid R Lynch, Melanie P Chin, Sylvia Boesch, et al.Journal of Diabetes and Its Complications|October 16, 2018
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney diseaseGlenn M Chertow, Gerald B Appel, Geoffrey A Block, et al.The Lancet. Global Health|March 22, 2015
Effect of a comprehensive programme to provide universal access to care for sputum-smear-positive multidrug-resistant tuberculosis in China: a before-and-after studyRenzhong Li, Yunzhou Ruan, Qiang Sun, et al.Annals of Neurology|October 17, 2020
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)David R Lynch, Melanie P Chin, Martin B Delatycki, et al.Plos One|May 3, 2014
Diagnostic accuracy of the PURE-LAMP test for pulmonary tuberculosis at the county-level laboratory in ChinaXichao Ou, Qiang Li, Hui Xia, et al.Preventing Chronic Disease|February 18, 2010
Perceptions of cardiovascular health in underserved communitiesLucinda L Bryant, Nancy P Chin, Lesley A Cottrell, et al.Bulletin of the World Health Organization|November 10, 2015
Cost-effectiveness of a comprehensive programme for drug-resistant tuberculosis in ChinaChristopher Fitzpatrick, Zhang Hui, Wang Lixia, et al.Plos Medicine|September 16, 2015
Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised TrialXiaoqiu Liu, James J Lewis, Hui Zhang, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 3, 2014
A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in ChinaXichao Ou, Hui Xia, Qiang Li, et al.Oncotargets and Therapy|September 19, 2017
Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumorsBen C Creelan, Dmitry I Gabrilovich, Jhanelle E Gray, et al.Pageof 56